Latest News Releases From The Newsroom
Mesoblast Faces Regulatory Setback; Nikola's Earnings: A Preview
August 04th, 2023
Mesoblast Limited (Nasdaq: MESO) has announced the receipt of a comprehensive response from the US Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) resubmission for remestemcel-L. The FDA's response stipulates the . Read more
Exceeding Forecasts: Booking Holdings and Trupanion's Q2 Earnings
August 03rd, 2023
Shares of Booking Holdings Inc. (Nasdaq: BKNG) experienced a remarkable after-hours surge of over 10% following the release of its second-quarter 2023 financial results. The company outperformed expectations with an earnings per share (EPS) of $37. Read more
SEC Obtains Emergency Relief to Halt Utah-Based Company's Crypto Asset Fraud Scheme Involving 18 Defendant
August 03rd, 2023
FOR IMMEDIATE RELEASE 2023-146 Washington D.C. / CRWE PRESS RELEASE / Aug. 3, 2023 - The Securities and Exchange Commission today announced that it obtained a temporary asset freeze, restraining order, and other emergency relief agains. Read more
NeuBase Makes Strategic Move; EZ Detect's Expanded Reach Fuels Biomerica
August 03rd, 2023
NeuBase Therapeutics, Inc. (Nasdaq: NBSE) announced a pause in its program development. Instead, NeuBase will explore strategic options, including acquisitions, mergers, and other transactions, with the goal of maximizing shareholder value. Accord. Read more
Q2 Earnings: Regeneron and Cigna Outperform Expectations
August 03rd, 2023
Shares of Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) surged over 5% in pre-market trading following an impressive second quarter 2023 earnings report. The company exceeded expectations, reporting adjusted earnings per share (EPS) of $10.24 and re. Read more
Earnings Showdown: Murphy Oil Beats Estimates, Spirit Airlines Falls Short
August 03rd, 2023
Murphy Oil Corporation (NYSE: MUR) announced its second quarter 2023 financial results, revealing adjusted earnings per share (EPS) of $0.79 and revenues of $814.59 million. The company's performance exceeded the consensus estimate of $0.78 on revenu. Read more
$7.5M Stock Buyback Ignites Equillium; Upbeat Earnings Boost Upwork
August 03rd, 2023
Shares of Equillium, Inc. (Nasdaq: EQ) surged in the extended session after the company announced an up to $7.5 million stock buyback program. $EQ was trading at $0.96 in after-hours, up $0.21 (+28.01%) In other news, Upwork Inc. (Nasdaq: UPWK). Read more
CVS Health Posts Upbeat Earnings, Johnson Controls Mixed Results
August 02nd, 2023
CVS Health Corporation (NYSE: CVS) announced second quarter 2023 adjusted earnings per share (EPS) of $2.21 and recorded revenues of $88.92 billion, surpassing the consensus EPS estimate of $2.11 on revenues of $86.45 billion. The company confirme. Read more
Waters and DuPont Beat Estimates, Unveil Below-Consensus Outlook
August 02nd, 2023
Waters Corporation (NYSE: WAT) delivered strong second quarter 2023 results, reporting earnings per share (EPS) of $2.80 and revenues of $740.58 million, surpassing the consensus EPS estimate of $2.59 on revenue of $734.45 million. Looking ahead, . Read more
Newsflash: HII Inks Major Multiyear Contract; Cardlytics Beats Estimates
August 01st, 2023
HII's (NYSE: HII) Ingalls Shipbuilding division has been awarded a significant fixed-price incentive multiyear contract for constructing six DDG 51 class ships, with deliveries spanning fiscal years 2023 to 2027. The contract includes option. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
February 27th, 2026February 26th, 2026
Treasury Sanctions Nicaraguan Officials Enabling the Murillo-Ortega Dictatorship's Repression
February 26th, 2026Kansas City Storm Names Cecil Stockdale as Head Coach for 2026 NJCP Season
February 26th, 2026




Member Login